Keyphrases
Lentiviral Vector
100%
Haemophilia A Mice
64%
Liver Sinusoidal Endothelial Cells
58%
Hemophilia
56%
Gene Therapy
37%
Immune Response
36%
Superparamagnetic Iron Oxide Nanoparticles (SPIONs)
32%
Conjugated Linoleic Acid
29%
Long-term Corrections
24%
Transgene Expression
23%
F8 Gene
21%
Immune Tolerance Induction
18%
Severe Haemophilia A
18%
Coagulation
18%
Cell-specific Promoters
18%
Factor VIII Activity
18%
AKT1
16%
Host Cell
16%
Tumor Targeting
16%
Magnetic Nanoparticles
16%
Tumor Cell Proliferation
16%
Native Promoter
16%
Malignant Pleural Mesothelioma
16%
Fatty Liver
16%
Adenosine A2A Receptor (A2AR)
16%
Ischemia-reperfusion Injury
16%
Apoptosis Signal-regulating Kinase 1 (ASK1)
16%
Vector Interaction
16%
Liver Cell Transplantation
16%
Fetal Liver Cells
16%
Mesothelioma Cells
16%
Opposite Effects
16%
Sirtuin 1 (SIRT1)
16%
Acid Effect
16%
Tumor Cell Viability
16%
Anticancer Properties
16%
Linoleic Acid
16%
GP64
16%
Stabilin-2
16%
Silica
16%
Myeloid Cells
16%
Pseudotyped Lentiviral Vector
16%
Therapeutic Potential
16%
Exon 21
16%
Engraftment
16%
Immune Tolerance
16%
Functional Characterization
16%
Busulfan
16%
Splice Variant
16%
Transcriptional Regulation
16%
Medicine and Dentistry
Haemophilia A
53%
Blood Clotting Factor 8
38%
Endothelial Cell
27%
Lentivirus Vector
27%
Promoter Region
22%
Immune Response
20%
Immunological Tolerance
17%
Reperfusion Injury
16%
Hepatocyte Transplantation
16%
Fatty Liver
16%
Neonatal Infant
10%
Engraftment
10%
Busulfan
10%
Transgene
9%
CGS-21680
9%
Liver Ischemia
9%
2 Chloro 6 N Cyclopentyladenosine
9%
Vesiculovirus
8%
Hepatocyte
7%
Gene Therapy
7%
Bleeding
6%
Hematopoietic Cell
5%
Liver Cell
5%
Biochemistry, Genetics and Molecular Biology
Haemophilia A
53%
Factor VIII
52%
Lentivirus Vector
43%
Promoter Region
34%
Gene Therapy
28%
Immune Response
18%
AKT1
16%
ASK1
16%
Sirtuin1
16%
Reperfusion
16%
Agonist
8%
Binding Site
8%
Vesiculovirus
8%
CGS-21680
8%
Isoform
5%
Hepatocyte
5%
DNA-binding Domain
5%
Upregulation
5%
Target Cell
5%
in Vivo Gene Transfer
5%
